Toronto Stock Exchange · Healthcare
Invest in Spectral Medical stock from India
Indian and foreign residents can buy Spectral Medical (EDT) shares directly through Paasa.
By Paasa · Updated
Spectral Medical at a glance
- Price
- CA$1.14-CA$0.03 (2.56%)
- Market cap
- CA$334.50M
- Day range
- CA$1.14 – CA$1.18
- P/E
- -8.86
- Dividend yield
- None
- Volume
- 12.58K
- 1 month
- -14.29%
- 6 months
- -20.28%
- YTD
- -20.83%
- 1 year
- -25.00%
- 5 years
- +256.25%
Spectral Medical statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CA$2.4M | CA$2.3M | CA$1.6M | CA$1.7M | CA$2.0M |
| Gross profit | −CA$5.2M | CA$1.0M | CA$662.0K | CA$983.0K | CA$1.2M |
| Operating income | −CA$11.7M | −CA$12.0M | −CA$11.4M | −CA$8.4M | −CA$6.7M |
| Net income | −CA$47.7M | −CA$15.4M | −CA$15.7M | −CA$11.3M | −CA$8.8M |
| Earnings per share | −CA$0.17 | −CA$0.05 | −CA$0.06 | −CA$0.04 | −CA$0.03 |
| EBITDA | −CA$42.3M | −CA$12.0M | −CA$14.0M | −CA$7.2M | −CA$6.4M |
| Total assets | CA$6.1M | CA$5.3M | CA$5.2M | CA$12.0M | CA$11.6M |
| Total debt | CA$21.1M | CA$14.9M | CA$8.6M | CA$7.6M | CA$582.0K |
| Cash and short-term investments | CA$4.1M | CA$3.0M | CA$3.0M | CA$8.4M | CA$8.9M |
| Shareholders' equity | −CA$69.7M | −CA$27.5M | −CA$16.5M | −CA$2.6M | CA$4.1M |
| Operating cash flow | −CA$9.5M | −CA$8.8M | −CA$10.7M | −CA$9.9M | −CA$8.7M |
| Free cash flow | −CA$9.7M | −CA$8.8M | −CA$10.9M | −CA$9.9M | −CA$9.2M |
| Capital expenditure | −CA$195.0K | −CA$27.0K | −CA$185.0K | −CA$33.0K | −CA$483.0K |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CAD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Kneat | KSI.TO | CA$6.50 | CA$624.86M |
| Fennec Pharmaceuticals | FRX.TO | CA$15.43 | CA$535.99M |
| Eupraxia Pharmaceuticals | EPRX.TO | CA$12.83 | CA$461.08M |
| Cipher Pharmaceuticals | CPH.TO | CA$13.69 | CA$347.61M |
| Cresco Labs | CL.CN | $0.97 | $343.60M |
| High Tide | HITI.V | CA$3.89 | CA$341.81M |
| Aurora Cannabis | ACB.TO | CA$5.52 | CA$341.61M |
| Profound Medical | PRN.TO | CA$8.30 | CA$301.60M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Spectral Medical from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CAD when you buy.
Step 3
Search EDT and buy
Find Spectral Medical by name or by its ticker, EDT, and place your order.
Why invest in Spectral Medical from India
What Spectral Medical does
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. Spectral Medical operates in the Medical - Diagnostics & Research industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Spectral Medical stock from India?
Yes. Indian residents and NRIs can buy Spectral Medical (EDT) shares directly through Paasa. Spectral Medical is listed on the Toronto Stock Exchange, in the Medical - Diagnostics & Research industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Spectral Medical shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CAD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.